Ostorhazi, Eszter, Hoffmann, Ralf, Herth, Nicole, Wade, John D., Kraus, Carl N., Otvos Jr., Laszlo (2018) Advantage of a Narrow Spectrum Host Defense (Antimicrobial) Peptide Over a Broad Spectrum Analog in Preclinical Drug Development. Frontiers in Chemistry, 6. doi:10.3389/fchem.2018.00359
Reference Type | Journal (article/letter/editorial) | ||
---|---|---|---|
Title | Advantage of a Narrow Spectrum Host Defense (Antimicrobial) Peptide Over a Broad Spectrum Analog in Preclinical Drug Development | ||
Journal | Frontiers in Chemistry | ||
Authors | Ostorhazi, Eszter | Author | |
Hoffmann, Ralf | Author | ||
Herth, Nicole | Author | ||
Wade, John D. | Author | ||
Kraus, Carl N. | Author | ||
Otvos Jr., Laszlo | Author | ||
Year | 2018 (August 21) | Volume | 6 |
Publisher | Frontiers Media SA | ||
DOI | doi:10.3389/fchem.2018.00359Search in ResearchGate | ||
Generate Citation Formats | |||
Mindat Ref. ID | 15657986 | Long-form Identifier | mindat:1:5:15657986:7 |
GUID | 0 | ||
Full Reference | Ostorhazi, Eszter, Hoffmann, Ralf, Herth, Nicole, Wade, John D., Kraus, Carl N., Otvos Jr., Laszlo (2018) Advantage of a Narrow Spectrum Host Defense (Antimicrobial) Peptide Over a Broad Spectrum Analog in Preclinical Drug Development. Frontiers in Chemistry, 6. doi:10.3389/fchem.2018.00359 | ||
Plain Text | Ostorhazi, Eszter, Hoffmann, Ralf, Herth, Nicole, Wade, John D., Kraus, Carl N., Otvos Jr., Laszlo (2018) Advantage of a Narrow Spectrum Host Defense (Antimicrobial) Peptide Over a Broad Spectrum Analog in Preclinical Drug Development. Frontiers in Chemistry, 6. doi:10.3389/fchem.2018.00359 | ||
In | (2019) Frontiers in Chemistry Vol. 6. Frontiers Media SA |
See Also
These are possibly similar items as determined by title/reference text matching only.